Prenetics Global Limited (PRE)

HK — Healthcare Sector
Peers: NEOG  QGEN  OLK  ACRS  SYNH  FONR  BNR  SERA  LMDX  GTH  BDSX  CSTL  MDXH  NOTV  DRIO  XGN 

Automate Your Wheel Strategy on PRE

With Tiblio's Option Bot, you can configure your own wheel strategy including PRE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PRE
  • Rev/Share 2.4101
  • Book/Share 13.4864
  • PB 0.7457
  • Debt/Equity 0.0339
  • CurrentRatio 2.3569
  • ROIC -0.2347

 

  • MktCap 130339800.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE -2.7438
  • Debt/Assets 0.027
  • DivYield 0
  • ROE -0.2514

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Prenetics Global Limited (PRE)

  • IPO Date 2021-07-16
  • Website https://www.prenetics.com
  • Industry Medical - Diagnostics & Research
  • CEO Mr. Sheng Wu Yeung
  • Employees 285
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.